Patrick Noel1, Marius Nedelcu2, Imane Eddbali1, Thierry Manos3, Michel Gagner4. 1. The American Surgecenter, Abu Dhabi, United Arab Emirates. 2. Centre Chirurgical de l'Obesite, Clinique Saint Michel, Toulon, France; Centre Hospitalier Universitaire Montpellier, Montpellier, France. Electronic address: marius.nedelcu@spitalulsfconstantin.ro. 3. Bouchard Clinic, Marseille, France. 4. Professor of surgery, Sacre Cœur Hospital, Montreal, Canada.
Abstract
BACKGROUND: Laparoscopic sleeve gastrectomy (LSG) became the most frequent bariatric procedure performed in France (2011) and in the United States (2013), but studies reporting long-term results are still rare. SETTING: Private hospital, France. METHODS: This is a retrospective analysis of a prospective cohort of 168 patients who underwent LSG between 2005 and 2008. The objective of this study was to present the 8-year outcome concerning weight loss, modification of co-morbidities, and to report the revisional surgery after sleeve. RESULTS: The preoperative mean body mass index was 42.8 kg/m2 (31.1-77.9), 35 patients were super obese, and 64 patients had a previous gastric band. For LSG as a definitive bariatric procedure, 8 years of follow-up data were available for 116 patients (follow-up: 69%). Of the remainder, 23 patients underwent revisional surgery and 29 were lost to follow-up. For the entire cohort, the mean excess weight loss (EWL) was 76% (0-149) at 5 years and 67% (4-135) at 8 years, respectively. Of the 116 patients with 8 years of follow-up, 82 patients had>50% EWL at 8 years (70.7%). Percentages of co-morbidities resolved were hypertension, 59.4%; type 2 diabetes, 43.4%; and obstructive sleep apnea, 72.4%. Twenty-three patients had revisional surgery for weight regain (n = 14) or for severe reflux (n = 9) at a mean period of 50 months (9-96). Twelve patients underwent resleeve gastrectomy, 6 patients underwent conversion to a bypass, and 5 patients to duodenal switch (1 single anastomosis duodeno-ileostomy). A total of 31% of patients reported gastroesophageal reflux symptoms at 8 years. CONCLUSIONS: At 8 years postoperatively, the LSG as a definitive bariatric procedure remained effective for 59% of cases. The results appear to be more favorable especially for the non-super-obese patients and primary procedures. LSG is a well-tolerated bariatric procedure with low long-term complication rates.
BACKGROUND: Laparoscopic sleeve gastrectomy (LSG) became the most frequent bariatric procedure performed in France (2011) and in the United States (2013), but studies reporting long-term results are still rare. SETTING: Private hospital, France. METHODS: This is a retrospective analysis of a prospective cohort of 168 patients who underwent LSG between 2005 and 2008. The objective of this study was to present the 8-year outcome concerning weight loss, modification of co-morbidities, and to report the revisional surgery after sleeve. RESULTS: The preoperative mean body mass index was 42.8 kg/m2 (31.1-77.9), 35 patients were super obese, and 64 patients had a previous gastric band. For LSG as a definitive bariatric procedure, 8 years of follow-up data were available for 116 patients (follow-up: 69%). Of the remainder, 23 patients underwent revisional surgery and 29 were lost to follow-up. For the entire cohort, the mean excess weight loss (EWL) was 76% (0-149) at 5 years and 67% (4-135) at 8 years, respectively. Of the 116 patients with 8 years of follow-up, 82 patients had>50% EWL at 8 years (70.7%). Percentages of co-morbidities resolved were hypertension, 59.4%; type 2 diabetes, 43.4%; and obstructive sleep apnea, 72.4%. Twenty-three patients had revisional surgery for weight regain (n = 14) or for severe reflux (n = 9) at a mean period of 50 months (9-96). Twelve patients underwent resleeve gastrectomy, 6 patients underwent conversion to a bypass, and 5 patients to duodenal switch (1 single anastomosis duodeno-ileostomy). A total of 31% of patients reported gastroesophageal reflux symptoms at 8 years. CONCLUSIONS: At 8 years postoperatively, the LSG as a definitive bariatric procedure remained effective for 59% of cases. The results appear to be more favorable especially for the non-super-obesepatients and primary procedures. LSG is a well-tolerated bariatric procedure with low long-term complication rates.
Authors: Daniel M Felsenreich; Lukas M Ladinig; Philipp Beckerhinn; Christoph Sperker; Katrin Schwameis; Michael Krebs; Julia Jedamzik; Magdalena Eilenberg; Christoph Bichler; Gerhard Prager; Felix B Langer Journal: Obes Surg Date: 2018-11 Impact factor: 4.129
Authors: Corey J Lager; Nazanene H Esfandiari; Yingying Luo; Angela R Subauste; Andrew T Kraftson; Morton B Brown; Oliver A Varban; Rasimcan Meral; Ruth B Cassidy; Catherine K Nay; Amy L Lockwood; Darlene Bellers; Colleen M Buda; Elif A Oral Journal: Obes Surg Date: 2018-11 Impact factor: 4.129